DK0784703T3 - Lamininkæder: Diagnostisk og terapeutisk anvendelse - Google Patents

Lamininkæder: Diagnostisk og terapeutisk anvendelse

Info

Publication number
DK0784703T3
DK0784703T3 DK95935428T DK95935428T DK0784703T3 DK 0784703 T3 DK0784703 T3 DK 0784703T3 DK 95935428 T DK95935428 T DK 95935428T DK 95935428 T DK95935428 T DK 95935428T DK 0784703 T3 DK0784703 T3 DK 0784703T3
Authority
DK
Denmark
Prior art keywords
diagnostic
therapeutic use
laminin chains
laminin
chains
Prior art date
Application number
DK95935428T
Other languages
English (en)
Inventor
Charles Pyke
Pekka Kallunki
Karl Tryggvason
Original Assignee
Karl Tryggvason
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karl Tryggvason filed Critical Karl Tryggvason
Application granted granted Critical
Publication of DK0784703T3 publication Critical patent/DK0784703T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95935428T 1994-10-04 1995-10-04 Lamininkæder: Diagnostisk og terapeutisk anvendelse DK0784703T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/317,450 US5660982A (en) 1994-10-04 1994-10-04 Laminin chains: diagnostic uses
PCT/EP1995/003918 WO1996010646A1 (en) 1994-10-04 1995-10-04 Laminin chains: diagnostic and therapeutic use

Publications (1)

Publication Number Publication Date
DK0784703T3 true DK0784703T3 (da) 1999-11-29

Family

ID=23233705

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95935428T DK0784703T3 (da) 1994-10-04 1995-10-04 Lamininkæder: Diagnostisk og terapeutisk anvendelse

Country Status (9)

Country Link
US (4) US5660982A (da)
EP (1) EP0784703B1 (da)
AT (1) ATE182180T1 (da)
AU (1) AU699183B2 (da)
DE (1) DE69510810T2 (da)
DK (1) DK0784703T3 (da)
ES (1) ES2133813T3 (da)
GR (1) GR3031488T3 (da)
WO (1) WO1996010646A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6153593A (en) * 1996-06-05 2000-11-28 The General Hospital Corporation Laminin 5 and the formation of basement membrane structure
AU740638B2 (en) * 1997-02-28 2001-11-08 Electro-Optical Sciences, Inc. Systems and methods for the multispectral imaging and characterization of skin tissue
WO1999019348A1 (en) * 1997-10-10 1999-04-22 The General Hospital Corporation Laminins and uses thereof
US6682911B1 (en) 1997-10-10 2004-01-27 The General Hospital Corporation Laminins and uses thereof
US6294356B1 (en) 1998-01-16 2001-09-25 Northwestern University Methods and materials for making and using laminin-5
US6573043B1 (en) * 1998-10-07 2003-06-03 Genentech, Inc. Tissue analysis and kits therefor
EP1177290A2 (en) * 1999-04-30 2002-02-06 Biostratum, Inc. Recombinant laminin 5
US6703363B1 (en) 1999-04-30 2004-03-09 Biostratum, Inc. Recombinant laminin 5
AU2001268233A1 (en) * 2000-06-08 2001-12-17 Chiron Corporation Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3
WO2002030465A2 (en) * 2000-10-12 2002-04-18 University Of Rochester Compositions that inhibit proliferation of cancer cells
US8613907B2 (en) 2000-10-12 2013-12-24 University Of Rochester Compositions that inhibit proliferation of cancer cells
US20040120959A1 (en) * 2001-01-08 2004-06-24 Karl Tryggvason Use of antibodies to the gamma 2 chain of laminin 5 to inhibit tumor growth and metastasis
DE10130800B4 (de) 2001-06-22 2005-06-23 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierung mit hoher Sensitivität
JPWO2003016907A1 (ja) * 2001-08-17 2004-12-02 エーザイ株式会社 生体試料中のラミニン５抗原の測定試薬及び測定方法
US6916618B2 (en) * 2002-01-24 2005-07-12 University Of Guelph Isolation of the lamin γ2 gene in horses and its use in diagnostic junctional epidermolysis bullosa
EP1578444A2 (en) * 2002-10-29 2005-09-28 Sirpa Salo Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasis
ES2564044T3 (es) * 2003-06-27 2016-03-17 DePuy Synthes Products, Inc. Células posparto derivadas de tejido del cordón umbilical y métodos de preparación y uso de las mismas
US20070065447A1 (en) * 2003-10-29 2007-03-22 Novo Nordisk A/S Laminin-5 gamma2-binding peptides, related compositions, and use thereof
US7985569B2 (en) 2003-11-19 2011-07-26 Danisco Us Inc. Cellulomonas 69B4 serine protease variants
US8535927B1 (en) 2003-11-19 2013-09-17 Danisco Us Inc. Micrococcineae serine protease polypeptides and compositions thereof
JP2008502588A (ja) * 2003-12-12 2008-01-31 ノボ　ノルディスク　アクティーゼルスカブ ラミニン−５調節物質及びその使用
WO2005079508A2 (en) * 2004-02-17 2005-09-01 Cancervax Corporation Method and composition for angiogenesis inhibition
US20050220760A1 (en) * 2004-04-02 2005-10-06 Clemson University Novel immunotherapy
US20070014788A1 (en) * 2004-12-13 2007-01-18 Novo Nordisk A/S Laminin-5 modulators and uses thereof
CA2541037A1 (en) 2005-03-31 2006-09-30 Sherwood Services Ag Temperature regulating patient return electrode and return electrode monitoring system
WO2009032224A2 (en) * 2007-08-29 2009-03-12 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for inhibiting squamous cell carcinoma
US7618801B2 (en) 2007-10-30 2009-11-17 Danison US Inc. Streptomyces protease
JP2012530045A (ja) 2008-06-18 2012-11-29 カール トゥリッグバソン， ラミニン−３３２のドメインに対する抗体
US20140045196A1 (en) * 2012-08-13 2014-02-13 University Of Tokyo Methods of prognosis and diagnosis of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5152980A (en) * 1988-05-19 1992-10-06 The Beth Israel Hospital Association Induction of tolerance to a foreign antigen IL-2 receptor-binding substances

Also Published As

Publication number Publication date
WO1996010646A1 (en) 1996-04-11
US20030100529A1 (en) 2003-05-29
DE69510810T2 (de) 1999-11-04
US20050048518A1 (en) 2005-03-03
DE69510810D1 (de) 1999-08-19
US6143505A (en) 2000-11-07
ES2133813T3 (es) 1999-09-16
AU3745195A (en) 1996-04-26
EP0784703A1 (en) 1997-07-23
US5660982A (en) 1997-08-26
EP0784703B1 (en) 1999-07-14
GR3031488T3 (en) 2000-01-31
AU699183B2 (en) 1998-11-26
ATE182180T1 (de) 1999-07-15

Similar Documents

Publication Publication Date Title
DK0784703T3 (da) Lamininkæder: Diagnostisk og terapeutisk anvendelse
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
FR2703693B1 (fr) Procédé rapide de détermination d'une séquence d'ADN et application au séquençage et au diagnostic.
CY1105446T1 (el) Διαγνωση και θepαπεια διαταραχων που συνδεονται με aur1 και aur2
NO890496D0 (no) Fremgangsmaate og anordning for ikke-inntrengende akustisk undersoekelse av elastisiteten til mykt, biologisk vev.
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
NO890224L (no) Fremgangsmaate og anordning for medisinsk behandling av den patologiske tilstand av ben.
DE69736539D1 (de) System für eine on-line behandlung von zellulären blutbestandteilen, z.b. bluttplättchen die für therapeutische zwecke entnommen werden
DK43890D0 (da) Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
DE820303T1 (de) p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES
DE68928728D1 (de) Diagnose von retinoblastoma
DE69729954D1 (de) Identifizierungsverfahren für Substanzen die an das Pyk2 Polypeptid binden
NO963487L (no) Isolerte, tyrosinaseavledete peptider, samt anvendelser derav
DK0870036T3 (da) Syntetisk pattedyrs-alfa-N-acetylglucosaminidase og genetiske sekvenser kodende derfor
CA2201865A1 (en) Laminin chains: diagnostic and therapeutic use
DE69734890D1 (de) Rdgb-proteine
NO930406L (no) Spesifikke antistoffer mot aktiverte blodplater samt fremstilling derav
DE3765916D1 (de) Sonde zur einfuehrung in den verdauungs- oder ausscheidungstrakt des menschlichen oder tierischen koerpers, insbesondere lithotriptor-sonde.
UA33330A (uk) Спосіб діагностики ендогенної інтоксикації
ATA38797A (de) Polymere-infusionslösung zur anwendung bei der diagnose von tumoren, gegebenenfalls zu deren behandlung
NO890042D0 (no) Fremgangsmaate, preparat og analysesett for transferrin-variant-analyser for diagnose.